FDA Drug Application (125084) for ERBITUX by IMCLONE

Back to FDA Applications sponsored by IMCLONE

Application Number125084
Product Number001
FormVIAL; INTRAVENOUS
Dosage100mg/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameERBITUX
Active IngredientCETUXIMAB



Back to FDA Applications sponsored by IMCLONE